![Dale A. Stringfellow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dale A. Stringfellow
Plus aucun poste en cours
Profil
Dr. Stringfellow was President and CEO of Berlex Laboratories, from December 2000 until April, 2003.
Berlex is a wholly-owned subsidiary of Schering AG and is responsible for all of Schering's pharmaceutical operations in the U.S.
From 1995 to 2000, Dr. Stringfellow was President of Berlex Biosciences which is responsible for all of Schering's research and development in the U.S.
In August 2002, Dr. Stringfellow became Chairman of Collateral Therapeutics, a wholly-owned subsidiary of Schering AG.
He has been a director of Myriad Genetics Inc. since December 1991.
From July 1990 until April 1995, he was President, CEO and a director of Celtrix Pharmaceuticals.
Dr. Stringfellow has also held other positions including: Vice President and Senior Director of Preclinical Cancer Research at Bristol-Myers Company;
Anciens postes connus de Dale A. Stringfellow
| Sociétés | Poste | Fin |
|---|---|---|
Collateral Therapeutics, Inc.
 Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes non-surgical gene therapy products | Président | 11/10/2007 |
Berlex, Inc.
 Berlex, Inc. Pharmaceuticals: MajorHealth Technology Manufactured pharmaceutical products | President | 01/04/2003 |
| MYRIAD GENETICS, INC. | Directeur/Membre du Conseil | - |
Formation de Dale A. Stringfellow
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Manufactured pharmaceutical products | Health Technology |
Collateral Therapeutics, Inc.
Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes non-surgical gene therapy products | Commercial Services |
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
